Table 3– Daily duration and employed settings of high-frequency oscillation (HFO) and tracheal gas insufflation (TGI)
DayTreated with HFO-TGI#/returned to CMVTreated with CMV alone+/breathing without assistanceDied§Duration of daily HFO-TGIƒ hHFV FI,O2## %aw¶¶ cmH2Oaw drop along tracheal tube++,§§ cmH2OBias flow¶¶ L·min−1TGI flowƒƒ L·min−1Frequency¶¶ HzΔP¶¶ cmH2O
161/510/0011.5±6.685.7±8.729.9±4.26.2±1.540.9±9.36.4±0.94.1±0.784.7±7.5
256/485/0110.1±5.984.7±9.229.5±3.46.1±1.640.6±8.86.5±0.74.2±0.984.8±7.8
342/3818/009.9±6.284.5±8.930.0±4.26.7±1.740.8±9.26.6±0.93.9±0.685.7±7.9
437/3021/1110.9±6.884.8±9.029.2±4.56.6±1.242.1±10.26.6±0.94.0±0.785.7±7.0
517/1537/1412.7±7.287.3±8.630.2±4.56.2±1.746.3±10.56.6±0.74.2±0.886.0±5.9
615/1038/1111.9±6.889.1±8.331.4±5.46.2±1.747.3±10.86.6±0.84.3±0.987.3±5.4
711/739/3114.2±7.590.9±7.132.0±4.06.0±1.947.1±10.26.6±0.73.9±0.787.6±6.5
88/541/3113.5±7.789.7±7.930.4±5.74.8±1.949.7±11.16.4±0.84.1±1.087.8±5.2
95/238/7212.0±5.688.9±5.331.0±3.84.8±1.748.0±11.06.3±0.74.2±0.787.7±2.6
103/340/7017.0±5.190.0±3.332.0±4.44.7±2.353.3±11.66.3±0.64.4±1.084.1±4.2
  • Data are presented as n or mean±sd. CMV: conventional mechanical ventilation; HFV: high-frequency ventilator; FI,O2: inspiratory oxygen fraction; aw: mean airway pressure; ΔP: oscillatory pressure amplitude; Pa,O2: arterial oxygen tension; MOF: multiple organ failure; tr: mean tracheal pressure. #: total number of patients treated with HFO-TGI; 19 and 19 patients received intermittent HFO-TGI for ≤3 and ≥5 days, respectively. : total number of patients treated with HFO-TGI and then returned to CMV, after fulfilling the criteria for weaning from HFO-TGI (see Methods section and fig. 1). +: total number of patients treated with CMV alone because they did not fulfil the criterion for return to HFO-TGI (see Methods section and fig. 1). §: on days 2, 4, 5 and 9, five patients (one still on HFO-TGI and four on post-HFO-TGI CMV) died of MOF after achieving Pa,O2/FI,O2 >150 mmHg during their last HFO-TGI session; within days 5–9, six patients died (four of MOF, one of hypoxaemia and one of a iatrogenic pneumothorax not related to any study protocol intervention) while still on HFO-TGI and without achieving Pa,O2/FI,O2 >150 mmHg during that particular HFO-TGI session (see eResults section in the online supplementary material). ƒ: 124 (55.6%), 65 (29.1%) and 34 (15.2%) out of 223 of HFO-TGI sessions lasted <8, 8–18 and >18 h, respectively; in 16 patients, the maximum uninterrupted use of HFO-TGI ranged from 30.1–102.2 h; 177 (79.4%) out of the 223 sessions were administered to all 61 (100%) patients on days 1–4; after the morning of day 5, the remaining 46 (20.6%) sessions were administered to 19 (31.1%) patients. ##: HFV-set FI,O2 averaged over the duration of the daily HFO-TGI sessions; actually delivered FI,O2 was further increased by the use of 100% oxygen flow TGI; HFV FI,O2 was set at 100% during 1) the recruitment period, 2) the application of the additional recruitment algorithm (fig. 1) and 3) the 15-min periods preceding and 5-min periods corresponding to the physiological measurements of the stabilisation period. ¶¶: parameter value averaged over the duration of daily HFO-TGI. ++: average pressure drop determined by measuring the tr just prior to TGI initiation and after TGI discontinuation (see Methods section, fig. 1 and the eResults section in the online supplementary material); pressure drop ranged from 2.0–10.4 cmH2O depending on tracheal tube size, HFO frequency and ΔP, and presence of secretions; recent data [8] showed that under similar HFV settings and tracheal tube cuff leak conditions, the addition of a TGI flow similar to that used in the present study results in an average increase of 1.5 cmH2O in tr (see online supplementary material). §§: eight patients were already tracheotomised before study entry, whereas a further five patients were tracheotomised during the study intervention period; during 176 (78.9%) out of the 223 HFO-TGI sessions, 53 (86.9%) out of the 61 patients were ventilated through orotracheal tubes (inner diameter 8.19±0.30 mm, range 7.50–9.00 mm); during 47 (21.1%) out of the 223 HFO-TGI sessions, 13 (21.3%) out of the 61 patients were ventilated through tracheostomy tubes (inner diameter 8.58±0.11 mm, range 8.00–9.00 mm). ƒƒ: 50.6±2.2% (range 45.0–55.2%) of the minute ventilation of the pre-session CMV; TGI flow ranged 4.5–8.5 L·min−1.